GlassScriptPhysician profile
Denise L Buck
NPI 1083760599
$2,977.06
in general payments reported to CMS, 2019-2025
29 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $370 · 2020: $604 · 2021: $1,014 · 2022: $302 · 2023: $388 · 2024: $299.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $687.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $686.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $612.46 | 2019-2024 | Farxiga, Breztri, Airsupra |
| Lilly USA, LLC | $427.39 | 2019-2024 | Mounjaro |
| Abbvie INC. | $408.62 | 2021-2023 | Ubrelvy, Qulipta |
| Merck Sharp & Dohme LLC | $244.92 | 2019-2023 | Belsomra, Verquvo, Steglatro |
| Novo Nordisk INC | $215.84 | 2019-2022 | |
| Allergan, INC. | $207.33 | 2020 | |
| Glaxosmithkline, LLC. | $185.26 | 2019-2024 | Trelegy Ellipta, Arexvy, Shingrix |
| Amarin Pharma, INC. | $120.61 | 2020-2021 | |
| Pfizer INC. | $66.15 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $47.66 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $45.85 | 2021-2022 | |
| Amgen INC. | $37.86 | 2020-2021 | |
| Exact Sciences Corporation | $36.98 | 2023-2024 | Cologuard Collection Kit |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $32.92 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $31.05 | 2021 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $30.45 | 2020-2021 | |
| Corcept Therapeutics | $30.14 | 2024 | Korlym |
| Mylan Specialty L.P. | $27.39 | 2019-2021 | |
| Exeltis, USA INC. | $24.58 | 2023 | Slynd |
| Dexcom, INC. | $23.60 | 2021 | |
| Shire North American Group INC | $15.81 | 2019 | |
| Optos, INC. | $15.10 | 2020 | |
| Eisai INC. | $14.91 | 2020 | |
| Becton, Dickinson and Company | $13.73 | 2019 | |
| Collegium Pharmaceutical, INC. | $13.69 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $12.08 | 2021 | |
| Medtronic Minimed, INC. | $11.95 | 2020 | |
| Sanofi-Aventis U.S. LLC | $11.47 | 2019 | |
| Vistapharm, INC. | $11.26 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Denise Buck listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.